UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 134

Sortiert nach

Performance of FDG PET/CT in the clinical management of breast cancer

Radiology, 2013-02, Vol.266 (2), p.388

2013

Volltextzugriff (PDF)

Lymphoscintigraphy Can Select Breast Cancer Patients for Internal Mammary Chain Radiotherapy

International journal of radiation oncology, biology, physics, 2012-07, Vol.83 (4), p.1081-1088

2012

Volltextzugriff (PDF)

Distinct tumor protein p53 mutants in breast cancer subgroups

International journal of cancer, 2013-03, Vol.132 (5), p.1227-1231

2013

Volltextzugriff (PDF)

The sentinel node procedure in breast cancer: nuclear medicine as the starting point

Journal of Nuclear Medicine, 2011-03, Vol.52 (3), p.405-414

2011

Volltextzugriff (PDF)

Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer

Oncogene, 2002-10, Vol.21 (49), p.7593-7597

2002

Volltextzugriff (PDF)

Comparison between 18F-FDG PET image-derived indices for early prediction of response to neoadjuvant chemotherapy in breast cancer

The Journal of nuclear medicine (1978), 2013-03, Vol.54 (3), p.341-349

2013

Volltextzugriff (PDF)

Estrogen receptor‐positive/human epidermal growth factor receptor 2‐negative breast tumors

Cancer, 2013-06, Vol.119 (11), p.1960-1968

2013

Volltextzugriff (PDF)

The germline genetics of mild-to-moderate penetrance: An intriguing role of PRAME in multiple carcinogenesis

Genes & diseases, 2024-05, Vol.11 (3), p.101003-101003, Article 101003

2024

Volltextzugriff (PDF)

p53 in breast cancer subtypes and new insights into response to chemotherapy

Breast (Edinburgh), 2013-08, Vol.22, p.S27-S29

2013

Volltextzugriff (PDF)

Prospects in senology

Soins; la revue de référence infirmière, 2019-12, Vol.64 (841), p.56

2019

Volltextzugriff (PDF)

18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis

Breast cancer research : BCR, 2017-01, Vol.19 (1), p.3-3, Article 3

2017

Volltextzugriff (PDF)

Intraoperative Radiotherapy for Breast Cancer in Elderly Women

Clinical breast cancer, 2022-01, Vol.22 (1), p.e109-e113

2022

Volltextzugriff (PDF)

A Constitutional Activating MET Mutation Makes the Genetic Link between Malignancies and Chronic Inflammatory Diseases

Clinical cancer research, 2019-07, Vol.25 (14), p.4504-4515

2019

Volltextzugriff (PDF)

NF-kappa B genes have a major role in inflammatory breast cancer

BMC cancer, 2008-02, Vol.8 (1), p.41-41, Article 41

2008

Volltextzugriff (PDF)

Concomitant medication, comorbidity and survival in patients with breast cancer

Nature communications, 2024-04, Vol.15 (1), p.2966-2966, Article 2966

2024

Volltextzugriff (PDF)

Ovarian reserve in breast cancer: assessment with anti-Müllerian hormone

Reproductive biomedicine online, 2014-11, Vol.29 (5), p.573-580

2014

Volltextzugriff (PDF)

TP53 status and response to chemotherapy in breast cancer

Pathobiology (Basel), 2008-01, Vol.75 (2), p.132

2008

Volltextzugriff (PDF)

Abstract P5-03-06: Comparison of clinicopathological features and outcome of breast cancer in BRCA-mutation carriers, in patients with a family history without BRCA-mutation and in patients with sporadic disease

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-03-06

2020

Volltextzugriff (PDF)

High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target

Oncotarget, 2019-11, Vol.10 (61), p.6577-6588

2019

Volltextzugriff (PDF)

Cancer lobulaire infiltrant : épidémiologie, histoire naturelle, principes thérapeutiques

Imagerie de la femme, 2017-10, Vol.27 (3), p.190-196

2017

Volltextzugriff (PDF)

Non-genetic indications for risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)

Gynécologie, obstétrique, fertilité & sénologie, 2022-02, Vol.50 (2), p.107

2022

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(112)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(44)
Science & Technology
(40)
Life Sciences & Biomedicine
(39)
Female
(37)
Breast Cancer
(33)
Oncology
(26)
Breast Neoplasms - Pathology
(16)
Tumors
(16)
Cancer
(14)
Breast Neoplasms - Drug Therapy
(13)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Treatment Outcome
(12)
Life Sciences
(11)
Chemotherapy
(10)
Prognosis
(9)
Breast Neoplasms - Diagnostic Imaging
(8)
Breast Neoplasms - Genetics
(8)
Sciences Biologiques Et Medicales
(8)
Sciences Medicales
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Performance of FDG PET/CT in the clinical management of breast cancer

Lymphoscintigraphy Can Select Breast Cancer Patients for Internal Mammary Chain Radiotherapy

Contraception in breast cancer survivors from the FEERIC case-control study (performed on behalf of the Seintinelles research network)

Efficacy of Circulating Tumor Cell Count-Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: The STIC CTC Randomized Clinical Trial

Distinct tumor protein p53 mutants in breast cancer subgroups

The sentinel node procedure in breast cancer: nuclear medicine as the starting point

Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer

Comparison between 18F-FDG PET image-derived indices for early prediction of response to neoadjuvant chemotherapy in breast cancer

Estrogen receptor‐positive/human epidermal growth factor receptor 2‐negative breast tumors

The germline genetics of mild-to-moderate penetrance: An intriguing role of PRAME in multiple carcinogenesis

p53 in breast cancer subtypes and new insights into response to chemotherapy

Prospects in senology

Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy

18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis

Intraoperative Radiotherapy for Breast Cancer in Elderly Women

Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC

A Constitutional Activating MET Mutation Makes the Genetic Link between Malignancies and Chronic Inflammatory Diseases

NF-kappa B genes have a major role in inflammatory breast cancer

Concomitant medication, comorbidity and survival in patients with breast cancer

Ovarian reserve in breast cancer: assessment with anti-Müllerian hormone

TP53 status and response to chemotherapy in breast cancer

Abstract P5-03-06: Comparison of clinicopathological features and outcome of breast cancer in BRCA-mutation carriers, in patients with a family history without BRCA-mutation and in patients with sporadic disease

High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target

Cancer lobulaire infiltrant : épidémiologie, histoire naturelle, principes thérapeutiques

Non-genetic indications for risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)

Aktive Filter

Suchergebnisse filtern